Skip to content
Luna Metabolic
Menu

Head-to-head for women

Breeze Meds vs yourEra

Breeze Meds and yourEra both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.

Breeze Meds

Ranked #37 for women · Grade C

Best for: Women who want a simple all-50-states option and are willing to ask for the details the site does not publish.

Visit Breeze Meds
vs

yourEra

Higher score

Ranked #4 for women · Grade B

Best for: Women who want transparently priced semaglutide and tirzepatide plus an optional NAD+, microdosing, and coaching-and-labs menu on one account.

Visit yourEra

The verdict for women

Higher Luna Fit Score: yourEra

yourEra edges out Breeze Meds on the Luna Fit Score, 86 to 77 (B vs C). Women who want transparently priced semaglutide and tirzepatide plus an optional NAD+, microdosing, and coaching-and-labs menu on one account.

Breeze Meds is still a genuine option — a straightforward nationwide compounded programme with NAD+ alongside the GLP-1 line — but it publishes one headline price and very little else. Weigh the six women's-health factors below against your own priorities.

Side-by-side on the six factors

Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.

Breeze Meds yourEra
PCOS & hormonal suitability7484
Breeze
yourEra
Clinical oversight & labs7285
Breeze
yourEra
Price transparency7688
Breeze
yourEra
Nationwide access9590
Breeze
yourEra
Ongoing support7486
Breeze
yourEra
Cancellation fairness7082
Breeze
yourEra

Price, access & features

DetailBreeze MedsyourEra
Luna Fit Score77/100 · C86/100 · B
Overall rank#37#4
SemaglutideFrom $199/mo$199/mo
TirzepatideFrom $299/mo first month, $399/mo thereafter$299/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only

Breeze Meds

Ranked #37 · Grade C

What we like

  • Available in all 50 states, per their own FAQ
  • One inclusive price covering the consultation, prescription review and delivery
  • NAD+ injections available alongside the GLP-1 line for anyone treating metabolic health as one picture

The caveats

  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
  • Publishes a single "from $199" figure that names no molecule; the tirzepatide price ($299 first month, $399 after) only appears inside the intake funnel
  • Every quoted figure is for the lowest dose — the funnel says higher doses may cost more, so these are floors, not the price of a titrated dose

yourEra

Ranked #4 · Grade B

What we like

  • Publicly listed pricing on both molecules — semaglutide from $199/mo and tirzepatide from $299/mo — while many compounders hide price behind a quiz
  • Fuller menu beyond GLP-1: NAD+ and microdosing protocols, plus an optional membership adding 1:1 coaching, a nutritionist, and an at-home lab draw
  • Markets a 50-state licensed-clinician network, no insurance required, with HSA/FSA accepted

The caveats

  • Compounded semaglutide and tirzepatide are not FDA-approved the way brand Wegovy, Ozempic, or Zepbound are, and compounding access can tighten as brand shortages resolve
  • Mid-market pricing that sits above the cheapest compounders (roughly $99–$150)
  • Injectable only — no oral route and no brand-name lane

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Luna Fit Score; affiliate partners carry a capped 6-point edge in list order, never in the score itself. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Keep comparing Breeze Meds and yourEra against other providers we review for women.

Or browse the full comparison hub.